BRAF and melanoma: The two non-hotspot mutations detected in one NMZL case, L597Q and N581I, were previously found in BRAF V600 wild-type melanoma and their part in oncogenic cell transformation was functionally proven [62, 63] thus further supporting the role of mutant BRAF in NMZL development.